Saxe Jon S

Saxe Jon S is listed in filings as Director at VistaGen Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 11, 2025, including 2 public disclosures. Recent filings connect the profile to VistaGen Therapeutics, Inc. (VTGN). The current snapshot covers public activity from Sep 10, 2024 to Sep 11, 2025. Reported amounts are shown as $63.5K to $45.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.